With extreme weather events increasing due to climate change, experts about from the unpreparedness of the electricity ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

The Company’s Annual Information Form for the year ended Dec. 31, 2024. In addition, TC Energy filed its Form 40-F for the year ended Dec. 31, 2024 with the United States Securities and Exchange ...